PubRank

Michael I Koukourakis

Author PubWeight™ 86.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 20.08
2 Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006 2.34
3 Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration 2014 2.10
4 Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003 1.60
5 The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol 2010 1.45
6 Metastatic cancer cells from c-erbB-2 negative primary breast cancer maintain the original c-erbB-2/HIF1alpha phenotype. Cancer Biol Ther 2007 1.38
7 Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy 2009 1.38
8 LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol 2010 1.32
9 BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res 2004 1.31
10 c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin Cancer Res 2004 1.30
11 Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002 1.27
12 DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 2003 1.22
13 Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003 1.20
14 "Autophagic flux" in normal mouse tissues: focus on endogenous LC3A processing. Autophagy 2011 1.12
15 Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 2010 1.11
16 Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol 2006 1.04
17 The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol 2008 1.01
18 Hypoxia and activated VEGF/receptor pathway in multiple myeloma. Anticancer Res 2010 0.99
19 Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol 2006 0.99
20 High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas. Gynecol Oncol 2011 0.99
21 Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res 2011 0.99
22 Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. Leuk Lymphoma 2008 0.98
23 Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse. Int J Cancer 2004 0.97
24 Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis 2003 0.96
25 Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression. Mod Pathol 2006 0.95
26 Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol 2002 0.95
27 Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives. Crit Rev Oncol Hematol 2008 0.94
28 The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer. Cancer Biol Ther 2012 0.93
29 Establishment and validation of a method for multi-dose irradiation of cells in 96-well microplates. Biochem Biophys Res Commun 2013 0.93
30 The pathology of tumor stromatogenesis. Cancer Biol Ther 2007 0.91
31 Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis. Mod Pathol 2006 0.91
32 Autophagy patterns and prognosis in uveal melanomas. Mod Pathol 2011 0.90
33 Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia? Autophagy 2011 0.89
34 Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med 2007 0.89
35 The vascular network of tumours--what is it not for? J Pathol 2003 0.89
36 Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. Clin Cancer Res 2002 0.88
37 Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet Gynecol Scand 2004 0.87
38 Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol 2006 0.86
39 Node-related factors and survival in node-positive breast carcinomas. Breast 2005 0.85
40 LC3A-positive "stone-like" structures in cutaneous squamous cell carcinomas. Am J Dermatopathol 2011 0.84
41 Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Lett 2008 0.84
42 Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 2004 0.84
43 "Stromatogenesis" and tumor progression. Int J Surg Pathol 2004 0.84
44 Angiogenic factor expression in hepatic cirrhosis. Mediators Inflamm 2007 0.84
45 Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther 2014 0.83
46 Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. Hematol Oncol 2008 0.83
47 Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. Oncologist 2010 0.83
48 Lung autophagic response following exposure of mice to whole body irradiation, with and without amifostine. Biochem Biophys Res Commun 2010 0.83
49 Tumour angiogenesis: vascular growth and survival. APMIS 2004 0.83
50 Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. In Vivo 2009 0.81
51 Thymidine phosphorylase expression in gallbladder adenocarcinomas. Int J Surg Pathol 2002 0.81
52 Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease. Clin Imaging 2005 0.81
53 Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology. Biomarkers 2014 0.81
54 Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC). Anticancer Res 2008 0.80
55 Patterns of autophagy in urothelial cell carcinomas--the significance of "stone-like" structures (SLS) in transurethral resection biopsies. Urol Oncol 2012 0.80
56 Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer. Clin Exp Metastasis 2002 0.80
57 Computed tomography (CT) scan evaluation of late toxicity following hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) in breast cancer patients treated with conservative surgery. Am J Clin Oncol 2006 0.80
58 Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival. Clin Exp Metastasis 2011 0.80
59 LC3 immunostaining pitfalls. Histopathology 2013 0.80
60 The "stone-like" pattern of autophagy in human epithelial tumors and tumor-like lesions: an approach to the clinical outcome. Autophagy 2010 0.79
61 Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer. Anticancer Res 2005 0.79
62 Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas. Hematol Oncol Stem Cell Ther 2013 0.78
63 Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum Clin Oncol 2012 0.78
64 c-erbB-2 and the "triple-state" in early breast carcinomas. Med Oncol 2009 0.77
65 Narrow amifostine dose windows define radioprotection outcome, following fractionated whole-body irradiation of mice. In Vivo 2011 0.77
66 Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC). Urol Oncol 2010 0.76
67 Vascular endothelial growth factor expression in non-small cell lung cancer. Methods Mol Med 2003 0.76
68 Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity. Semin Oncol 2002 0.76
69 One-lung ventilation and HIF1alpha expression in lung cancer and pneumothorax. Anticancer Res 2010 0.76
70 Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity. Anticancer Drugs 2014 0.76
71 Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC). Med Oncol 2010 0.76
72 Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer. Int J Radiat Biol 2009 0.75
73 Non linear analysis of magnetoencephalographic signals as a tool for assessing malignant lesions of the brain: first results. Brain Topogr 2004 0.75
74 Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis. Med Oncol 2014 0.75
75 A plesiotherapy technique for the post-operative treatment of skin cancer using Ir192 microSelectron. J Appl Clin Med Phys 2008 0.75
76 Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression. Cytokine 2004 0.75